Relaxo Footwears Ltd. share price target

Relaxo Footwears Ltd.'s (Relaxo) Q4FY21 result was marginally above estimates on key parameters. Strong demand traction for mass product supported sales volume in Q4, while better product mix and savings in promotional expenses as well as prudent cost management led to EBITDA margin improvement. Net sales increased by 38.3% YoY to Rs7,477mn, while EBITDA was higher by 69.3% YoY to Rs1,629mn. The company reported net profit of Rs1,022mn, higher by 97.2% over Q4FY20. After a robust Q4FY21, near term business may get impacted due to second wave of Covid-19 and statewide lockdown, however, we believe that Relaxo will continue to outperform the organized...

Based on the above themes we recommend the following stocks: ICICI Bank, SBI, Equitas SFB, Federal Bank, Bharti Airtel, HCL Tech, Tech Mahindra, Varun Beverages, Relaxo Footwears, Amber Enterprises, Camlin Fine Science, Minda Industries, Steel Strip Wheels. Lupin & ACC

Rural Growth Benefiting RelaxoRelaxo continues to perform well despite the country only beginning to recover from the negative impacts of the pandemic. The Q3FY21 results were above our expectations as rural India rebounded faster

This we believe will drive mix improvement with overall ASPs and Margins rising in H2FY21E in our view. We continue to maintain BUY with a TP of Rs. 925 we roll forward our target PE multiple of 57x to its FY23E EPS.

Resilient performance during challenging times builds our confidence in the business model and ability to gain market share. Though we believe current gross margins (59-61%) may not be sustainable in nature, we expect EBITDA margin improvement to sustain driven by operating leverage and cost control measures. Factoring in the performance of Q3FY21, we revise our earnings estimates upwards by ~7% for FY22/23E. We bake in revenue, earnings CAGR of 12%, 20%, respectively, in FY20-23E. Over the years, Relaxo has maintained balance sheet prudence with controlled working...

Relaxo Footwear(RLXF)reported better than expected Q2FY21 on the back of 2% volume growth. The company witnessed strong recovery as ~65% of the revenue is dominated by mass footwearrange (

We recommend a BUY on RELAXO FOOTWEAR with a Target Price of Rs 816, an upside of 7% from CMP of Rs. 763 and Stop Loss Rs 710

Relaxo Footwear(RLXF) for Q2FY21 reported revenue at Rs. 576 cr on the back of 2% volume growth (22.5% above our estimates) as compared to Rs. 622 cr in the corresponding quarter of the previous year, 7.4% lower YoY.

Gross Margins - A Positive Surprise: Revenue for Q2FY21 was 7.4percent lower on YoY basis but EBITDA was up significantly,at 21.2percent on account of higher gross margins and good cost control measures.Gross margins were higher by 505 bps on account of lower inventory, tradedgoods and commodity prices.

As most people are working from home, sales of sandals, flip flops have seen a significant surge in demand. Relaxo being a dominant player in the aforesaid categories, through its strong portfolio of brands (Flite', Bahamas', Hawaii') has witnessed a swift recovery in volumes and captured market share from unorganised players in H1FY21. While sale of shoes continues to be laggards (sports, canvas), green shoots are visible with gradual opening up of the economy. Further, on festive demand trends, healthy traction has been seen in October in most regions except Kerala....